1. Home
  2. BP vs MDT Comparison

BP vs MDT Comparison

Compare BP & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BP p.l.c.

BP

BP p.l.c.

HOLD

Current Price

$39.22

Market Cap

114.3B

Sector

Energy

ML Signal

HOLD

Logo Medtronic plc.

MDT

Medtronic plc.

HOLD

Current Price

$82.07

Market Cap

105.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BP
MDT
Founded
1889
1949
Country
United Kingdom
Ireland
Employees
93700
N/A
Industry
Integrated oil Companies
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.3B
105.3B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BP
MDT
Price
$39.22
$82.07
Analyst Decision
Hold
Buy
Analyst Count
11
21
Target Price
$44.43
$108.21
AVG Volume (30 Days)
10.1M
8.9M
Earning Date
04-28-2026
06-03-2026
Dividend Yield
4.18%
3.58%
EPS Growth
N/A
3.32
EPS
N/A
3.73
Revenue
N/A
$36,364,000,000.00
Revenue This Year
$13.52
$8.91
Revenue Next Year
N/A
$6.54
P/E Ratio
$11,332.35
$22.47
Revenue Growth
N/A
8.43
52 Week Low
$31.01
$73.31
52 Week High
$48.27
$106.33

Technical Indicators

Market Signals
Indicator
BP
MDT
Relative Strength Index (RSI) 45.85 55.26
Support Level $33.30 $77.88
Resistance Level $39.51 $82.83
Average True Range (ATR) 0.63 2.14
MACD 0.14 0.32
Stochastic Oscillator 62.46 53.76

Price Performance

Historical Comparison
BP
MDT

About BP BP p.l.c.

BP is an integrated energy company that explores for, produces, and refines oil and gas around the world. In 2025, it produced 1.2 million barrels of liquids and 6.5 billion cubic feet of natural gas per day. At the end of 2025, proved hydrocarbon reserves stood at 6.2 billion barrels of oil equivalent, 56% of which are liquids. The company operates refineries with a total crude distillation capacity of 1.56 million barrels of oil per day.

About MDT Medtronic plc.

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Share on Social Networks: